|1.||Hsieh, Fred: 1 article (04/2012)|
|2.||Farver, Carol: 1 article (04/2012)|
|3.||Sharp, Jacqueline: 1 article (04/2012)|
|4.||Loyd, James E: 1 article (04/2012)|
|5.||Erzurum, Serpil C: 1 article (04/2012)|
|6.||Asosingh, Kewal: 1 article (04/2012)|
|7.||Park, Margaret: 1 article (04/2012)|
|8.||Tang, W H Wilson: 1 article (04/2012)|
|9.||Farha, Samar: 1 article (04/2012)|
|10.||Thomas, Jim: 1 article (04/2012)|
|1.||Mastocytosis (Mast-Cell Disease)
06/01/1995 - "These data indicate that quantification of the urinary excretion of PGD-M is a more sensitive biochemical diagnostic indicator of mastocytosis than is the quantification of NT-methylhistamine."
06/01/1995 - "Urinary excretion of NT-methylhistamine and PGD-M was measured in 46 urine samples from 17 patients with histologically documented mastocytosis. "
06/01/1995 - "Therefore, we examined the correlation between the urinary excretion of the histamine metabolite, NT-methylhistamine, and PGD-M in urine samples from patients with mastocytosis. "
06/01/1995 - "Recently, we developed an assay for the major urinary metabolite of PGD2 (PGD-M), 9 alpha,11 beta-dihydroxy-15-oxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid, and demonstrated that urinary excretion of this compound is markedly increased in patients with mastocytosis. "
|2.||Asthma (Bronchial Asthma)
04/01/2012 - "Serum total tryptase was higher in PAH than that in controls suggesting greater numbers of mast cells, but indicators of mast cell activation (mature tryptase, LTE(4) and PGD-M) were similar among PAH, asthma, and controls. "
04/01/2012 - "To test this, blood and urine were collected from patients with PAH (N=44), asthma (N=18) and healthy controls (N=29) to quantitate biomarkers of total body mast cell numbers and activation (total and mature tryptase, N-methyl histamine, leukotriene LTE(4) and prostaglandin PGD-M). "
|1.||Histamine (Histamine Dihydrochloride)
|3.||Biological Markers (Surrogate Marker)